Pomalidomide Medication Guide

Pomalidomide, as an important cancer-targeted drug, plays an important role in the treatment of multiple myeloma. It belongs to the class of immunomodulator drugs. It can effectively slow down the progression of the disease and improve the quality of life of patients by inhibiting the proliferation of tumor cells, inducing apoptosis, and regulating immune system functions. In order to ensure the best efficacy of pomalidomide and reduce the occurrence of adverse reactions, patients should follow the following medication guidelines when using it:

Pomalidomide is usually available as an oral tablet, and the recommended dosage is 4 mg daily on days 1-21. At the same time, in order to enhance the efficacy, it is often used in combination with low-dose dexamethasone, specifically 40 mg of dexamethasone is given on days 1, 8, 15 and 22 (for patients older than 75 years old, the dexamethasone dose is adjusted to 20 mg). This regimen is usually continued until the patient's disease progresses or unacceptable toxicity occurs.

In terms of taking time, in order to maintain a stable concentration of the drug in the body, it is recommended to take pomalidomide at the same time every day, and it is best to take it on an empty stomach, that is, at least 2 hours before a meal or 2 hours after a meal. This helps reduce the impact of food on drug absorption and ensures maximum efficacy. However, if the patient develops stomach discomfort after taking it on an empty stomach, it can also be taken after a meal, but a certain period of time should be ensured with food.

While taking pomalidomide, patients require regular medical monitoring and follow-up to evaluate drug efficacy and safety. This includes blood tests, bone marrow biopsies, etc. so that any potential side effects or complications can be detected and dealt with promptly. Common side effects include hematological adverse reactions (such as anemia, thrombocytopenia), infection, nausea, fatigue, etc. If patients encounter any discomfort or questions during use, they should consult a doctor or pharmacist in time.

Additionally, pomalidomide may interact with other medications, so inform your doctor of all prescription, over-the-counter, and supplements you are taking before use. Especially those that may affect immune system function or blood thinners require special attention.

In conclusion, pomalidomide is an effective drug for the treatment of multiple myeloma, and compliance with its medication guidelines is crucial to ensure efficacy and safety. Patients should use medications rationally under the guidance of a doctor, and pay close attention to their own condition and drug reactions.

xa0

Reference: https://pmc.ncbi.nlm.nih.gov/articles/PMC4093466/